Bayer Aspirin News
- Fantasia faces reality after suicide attempt Wednesday, September 1, 2010 @ 3:34PMThe singer faces reality after a suicide attempt. She says she's on the road to recovery and ready to promote her new album.
- Rival clot drugs both poised to replaced problematic Warfarin Wednesday, September 1, 2010 @ 12:31PMBoth Bristol’s apixaban and Bayer’s Xarelto are racing to replace old, difficult-to-use anti-clotting drug, warfarin
- Experimental blood thinner apixaban is 50% better than aspirin at preventing strokes, study says Wednesday, September 1, 2010 @ 9:22AMResearchers have prematurely terminated a clinical trial of an experimental blood thinner because the drug proved to be much better than aspirin at preventing strokes caused by atrial fibrillation, researchers said Tuesday. The drug, called apixaban, is one of three new drugs that are expected to compete against the widely used blood thinner warfarin in a market that is thought to be worth at ...
- Pipeline Review: Bristol-Myers Squibb's 5 Keys to Success Wednesday, September 1, 2010 @ 7:10AMHere's its post-Plavix plan.
- Pfizer blood-thinner apixaban advances in tests Wednesday, September 1, 2010 @ 1:13AMOK, but does it beat rat poison?That's about the only question remaining after a late-stage study released Tuesday in Stockholm, Sweden, showed Pfizer Inc.'s experimental blood thinner apixaban was
- New Drugs Rival Warfarin as Blood Clot Preventer Tuesday, August 31, 2010 @ 6:36PMA Bristol-Myers drug shows promise in treating a heart rhythm disorder, and others combat postsurgical clotting and deep vein thrombosis.
- Today: H 32 /L 21 Tuesday, August 31, 2010 @ 5:41PMBEVERLY HILLS, CALI — —August was supposed to be Fantasia Barrino’s comeback month. For three years, the “American Idol” winner and Broadway star had been working on her third album, and selecting tracks that spoke to how far she’d come in her troubled life.
- Bristol, Bayer drugs effective Tuesday, August 31, 2010 @ 5:37PMThe drugmakers' rival anti-clotting drugs both proved safe and effective in clinical trials. Bayer's Xarelto helped dissolve potentially deadly clots in the legs and prevented new ones.
- Bristol, Bayer drugs effective Tuesday, August 31, 2010 @ 5:37PMThe drugmakers' rival anti-clotting drugs both proved safe and effective in clinical trials. Bayer's (OTCBB:BAYRY.ob - News) Xarelto helped dissolve potentially deadly clots in the legs and prevented new ones. Bristol-Myers Squibb's apixaban, commercialized with help from with Pfizer , reduced the risk of stroke by 52% vs. aspirin, researchers said.
- Companies race to develop drugs to reduce blood-clotting problems Tuesday, August 31, 2010 @ 10:56AMThe drugs are aimed at people who have a higher than normal risk for clotting or stroke, like patients undergoing hip replacement surgery or those with an irregular heartbeat.
- Bayer and Bristol's rival clot drugs both impress Tuesday, August 31, 2010 @ 10:42AMSTOCKHOLM (Reuters) - Rival anti-clotting drugs from Bayer and Bristol-Myers Squibb both impressed in clinical trials, keeping them firmly in the race to displace the old, problematic heart drug warfarin.
- Fantasia tells her story Tuesday, August 31, 2010 @ 10:39AMAugust was supposed to be Fantasia Barrino's comeback month. For three years, the "American Idol" winner and Broadway star had been working on her third album, and selecting tracks that spoke to how far she'd come in her troubled life.
- Bayer and Bristol's rival clot drugs both impress Tuesday, August 31, 2010 @ 10:23AMBy Ben Hirschler
- Pfizer/Bristol Blood Thinner Halves Stroke Rate In Study Tuesday, August 31, 2010 @ 8:58AMPfizer/Bristol Blood Thinner Halves Stroke Rate In Study
- Pfizer, Bayer set sights on blood-thinner med Tuesday, August 31, 2010 @ 8:09AMChris Ratcliffe/Bloomberg Boehringer Ingelheim GmbH may be the first drugmaker to win U.S. approval of a revolutionary alternative for preventing strokes. It likely won’t be the last. Pfizer, the world’s biggest drugmaker, and Bayer AG will present data at a...
- Pfizer, Bayer Studies Show Clot Drugs Are as Safe as Standard Treatment Tuesday, August 31, 2010 @ 7:53AMPfizer Inc. and Bayer AG revealed study results today that may give their medicines a foothold in a $10-billion-a-year market to prevent clots that cause strokes and deadly lung damage.
- Cuccinelli supports electronic recording systems in court Tuesday, August 31, 2010 @ 4:45AMRICHMOND Attorney General Ken Cuccinelli says courts can install electronic recording systems, which could cut down on the need for court reporters.
- Pfizer Clot Drug Beats Aspirin in Resarch, May Enter $10 Billion Market Tuesday, August 31, 2010 @ 2:00AMPfizer Inc. ’s experimental blood thinner apixaban beat aspirin in a study that may open the door to a $10 billion-a-year market to prevent clots that cause strokes and deadly lung damage.
- Pfizer, Bayer Fight to Replace Rat Poison in Stroke-Drug Market Sunday, August 29, 2010 @ 5:33PMBoehringer Ingelheim GmbH may be the first drugmaker to win U.S. approval of a revolutionary alternative for preventing strokes. It likely won’t be the last.
- Fantasia Barrino opens up about her dark days and her painful healing process Friday, August 27, 2010 @ 11:32AM"I was so numb. I was so out of it. I've never been to that place before. It was so scary. It was the darkest place that anybody would want to be."
- FDA Schedules Panel Review Of Blood-Thinning Drug Pradaxa Thursday, August 26, 2010 @ 1:13PMFDA Schedules Panel Review Of Blood-Thinning Drug Pradaxa
- Bayer, Bristol intensify battle for $20 bn anticoagulant market Tuesday, August 24, 2010 @ 3:15PMBayer, Bristol intensify battle for $20 bn anticoagulant marketBayer, Bristol intensify battle for $20 bn anticoagulant market
- Battle of anticoagulants to dominate heart meeting Tuesday, August 24, 2010 @ 9:07AMLONDON, Aug 24 — Rival anti-clotting pills being developed by Bayer and Bristol-Myers Squibb are both set to show positive results next week as the race intensifies to replace the old, problematic heart drug warfarin. At stake is a potential new market estimated at more than US$10 billion (RM31.2 billion) a year — and possibly as much as US$20 ...
- PREVIEW - Battle of anticoagulants to dominate heart meeting Tuesday, August 24, 2010 @ 7:42AMLONDON (Reuters) - Rival anti-clotting pills being developed by Bayer and Bristol-Myers Squibb are both set to show positive results next week as the race intensifies to replace the old, problematic heart drug warfarin.
- PREVIEW-Battle of anticoagulants to dominate heart meeting Tuesday, August 24, 2010 @ 7:09AM* Data on Bayer's Xarelto, Bristol's apixaban due on Aug 31
- Some urge school district to change medicine policy Tuesday, August 24, 2010 @ 12:04AMShould students be able to take pain relievers, decongestants and other over-the-counter medications at school without a doctor's permission?
- Bayer CropScience plant closing in Camden County Saturday, August 21, 2010 @ 6:24AMKINGSLAND - Bayer CropScience, one of the largest private employers in Camden County, is closing in about two years, costing 84 employees their jobs. The plant near Woodbine produces only one product, the insecticide Temik, which is sold worldwide for use on citrus, potatoes, cotton and other crops. Bayer voluntarily agreed to stop producing the insecticide by 2014 after the Environmental ...
- FDA extends review on Acetadote for non-acetaminophen acute liver failure Friday, August 20, 2010 @ 11:49PMCumberland Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration (FDA) has extended its review of the supplemental new drug application (sNDA) for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure.
- Study finds aspirin protects against colon cancer Saturday, August 14, 2010 @ 9:27AMA daily dose of aspirin can prevent cancer in people with a genetic disorder that increases their risk of developing the disease, scientists say.
- 'Idol' winner hospitalized in Charlotte after overdose Wednesday, August 11, 2010 @ 7:39AMCHARLOTTE -- “American Idol” winner Fantasia Barrino spent Monday night at a Charlotte hospital after what police are calling an overdose. Police were called to her home in south Charlotte just before 10 p.m. Monday and reported that she could...
- Fantasia Hospitalized In Charlotte Tuesday, August 10, 2010 @ 4:48PMAmerican Idol winner Fantasia Barrino spent Monday night at a Charlotte hospital after what police are calling an overdose.
- 911 Caller: Fantasia 'Slowly Losing Consciousness' Tuesday, August 10, 2010 @ 4:48PMA 911 caller said Fantasia Barrino was "slowly losing consciousness" after taking a bottle of aspirin.
- This Day in History - August 10 Tuesday, August 10, 2010 @ 3:36AMToday is the 222nd day of 2010. There are 143 days left in the year.
- WRAPUP 2-European chemicals post strong Q2 on volume gains Thursday, July 29, 2010 @ 7:57AMWRAPUP 2-European chemicals post strong Q2 on volume gains
- WRAPUP 1-Sanofi seeks Genzyme fix, Astra gets new drug lift Thursday, July 29, 2010 @ 7:34AMWRAPUP 1-Sanofi seeks Genzyme fix, Astra gets new drug lift
- WRAPUP 2-European chemicals post strong Q2 on volume gains Thursday, July 29, 2010 @ 7:17AM* BASF Q2 adj EBIT up 94 pct at 2.2 bln euros, beats poll
- Sanofi seeks Genzyme fix, Astra gets new drug lift Thursday, July 29, 2010 @ 7:12AMLONDON (Reuters) - Hopes for a smart acquisition and a new heart drug overshadowed forecast-beating results from Sanofi-Aventis and AstraZeneca on Thursday, underscoring pressure on both companies to reinvent themselves.
- Sanofi seeks Genzyme fix, Astra gets new drug lift Thursday, July 29, 2010 @ 6:47AMBy Ben Hirschler, European Pharmaceuticals Correspondent
- Bayer's 2nd-quarter profit down 1.3 percent Thursday, July 29, 2010 @ 6:43AMGermany's Bayer AG saw second-quarter net earnings slip by 1.3 percent as a stronger revenue was offset by one-time charges for lawsuits and writing down a cancer drug.
- Bayer's 2nd-quarter profit down 1.3 percent Thursday, July 29, 2010 @ 4:39AMGermany's Bayer posts slight decline in 2nd-quarter net profit to $682 million
- Bayer's 2nd-Quarter Profit Down 1.3 Percent Thursday, July 29, 2010 @ 4:29AMGermany's Bayer posts slight decline in 2nd-quarter net profit to $682 million Programming - NET - Component Frameworks - Bayer - Tools
- FACTBOX-UPDATE 1-Blood-thinning drugs may face new competition Wednesday, July 28, 2010 @ 6:12PM(Adds Lovenox, updates introduction with U.S. panel decision on Brilinta)
- Blood-thinning drugs may face new competition Wednesday, July 28, 2010 @ 2:06AM(Reuters) - AstraZeneca Plc is aiming to enter the multibillion-dollar global market for blood-thinning drugs with a new medicine called Brilinta.
- Carl Hiaasen book excerpt | First came the crash, then Skink's inconvenient truth Monday, July 26, 2010 @ 9:24PMThe following is an excerpt from Miami Herald columnist Carl Hiaasen's new novel Star Island (Knopf, 26.95), available Tuesday.
- CHECKUP Sunday, July 25, 2010 @ 5:49PMEddy Alzheimer's Services, a program of The Eddy not-for-profit network of senior services based in Troy, will offer a free educational program on "Travel Tips & Summer Safety" for families caring for older loved ones who have dementia, from 6 to 7 p.m. Tuesday at the Eddy Village Green Training Center, 300 Village Green Drive (access off 421 W. Columbia Street), Cohoes. The A-T Children's ...
- SSL International: Talk from the City lists potential counterbids Wednesday, July 21, 2010 @ 10:38AMNow that Reckitt Benckiser has put SSL International is firmly "in play", brokers have drawn up comprehensive lists of potential counterbidders.
- Can aspirin also help in cancer prevention? Tuesday, July 20, 2010 @ 5:45AMBayer first started selling aspirin as a pain and fever reliever over 100 years ago.
- Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care Tuesday, July 13, 2010 @ 11:14AMMORRISTOWN, N.J., July 12 /PRNewswire/ -- Timothy G. Hayes, currently Senior Vice President and Region Head for Bayer HealthCare's Consumer Care Division in North America, will also lead the business unit's Global Business Development function effective July 1. In addition to his role leading Bayer HealthCare's over-the-counter (OTC) drug business in the United States, Canada and Puerto Rico ...
- Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care Tuesday, July 13, 2010 @ 7:15AMTimothy G. Hayes, currently Senior Vice President and Region Head for Bayer HealthCare's Consumer Care Division in North America, will also lead the business unit's Global Business Development function effective July 1.
- Ten vie for two at-large School Board seats Monday, July 12, 2010 @ 8:26AMCandidates weigh in on schools issues before the Aug. 10 primary election. TANGLETOWN — If Minneapolis voters can count on one thing this fall, it’s this: Change is coming to the School Board.